Module Database Search
| MODULE DESCRIPTOR | |||
|---|---|---|---|
| Module Title | |||
| Clinical Immunology | |||
| Reference | AS3901 | Version | 4 |
| Created | August 2021 | SCQF Level | SCQF 9 |
| Approved | May 2011 | SCQF Points | 15 |
| Amended | September 2021 | ECTS Points | 7.5 |
| Aims of Module | |||
|---|---|---|---|
| To provide students with the ability to discuss the molecular and cellular basis of diseases affecting the immune system, and the applications of immunological techniques designed to diagnose and monitor them. | |||
| Learning Outcomes for Module | |
|---|---|
| On completion of this module, students are expected to be able to: | |
| 1 | Discuss lymphocyte activation and control, and the interaction of the immune system with antigen. |
| 2 | Explain the immunology of hypersensitivity, autoimmunity, immunodeficiency, transplantation and cancer. |
| 3 | Explain the features and applications of immunoassays in the diagnosis and monitoring of diseases affecting the immune system. |
| Indicative Module Content |
|---|
| Lymphocyte Activation & Control: first and second signals, accessory molecules, soluble immunoregulators (cytokines, interleukins, chemokines).Defence against Infection: vaccination, subversion by pathogens, superantigens. Hypersensitivity : types I to V. Autoimmunity: MHC, rheumatological (SLE, RA, autoantibodies) and kidney(Goodpastures) and organ-specific (thyroid, coeliac, pernicious anaemia, diabetes) diseases. Immunodeficiency: Complement, primary (T & B & NK cell) and secondary (HIV). Transplantation: rejection, solid organs, bone marrow. Cancer : tumour antigens, evasion. Immunoassays: haemagglutination, RIA, ELISA, tissue typing, functional assays. |
| Module Delivery |
|---|
| This is a lecture based module supplemented by tutorials and group discussions. |
| Indicative Student Workload | Full Time | Part Time |
|---|---|---|
| Contact Hours | 40 | N/A |
| Non-Contact Hours | 110 | N/A |
| Placement/Work-Based Learning Experience [Notional] Hours | N/A | N/A |
| TOTAL | 150 | N/A |
| Actual Placement hours for professional, statutory or regulatory body |
| ASSESSMENT PLAN | |||||
|---|---|---|---|---|---|
| If a major/minor model is used and box is ticked, % weightings below are indicative only. | |||||
| Component 1 | |||||
| Type: | Examination | Weighting: | 70% | Outcomes Assessed: | 2, 3 |
| Description: | Extended response questions | ||||
| Component 2 | |||||
| Type: | Coursework | Weighting: | 30% | Outcomes Assessed: | 1 |
| Description: | Problem solving exercise | ||||
| MODULE PERFORMANCE DESCRIPTOR | |
|---|---|
| Explanatory Text | |
| The first grade represents Component 1 (EX1) weighted as major and the second, Component 2 (CW1), weighted as minor. A minimum of Module Grade D is required to pass the module, with compensation of grade E in in Component 1 or Component 2 permitted. Non-submission of either component will result in an NS grade. | |
| Module Grade | Minimum Requirements to achieve Module Grade: |
| A | AA, AB |
| B | AC, AD, AE, BA, BB, BC, CA |
| C | BD, BE, CB, CC, CD, DA, DB |
| D | CE, DC, DD, DE, EA, EB, EC |
| E | AF, BF, CF, DF, ED, EE, EF, FA, FB, FC, FD |
| F | FE, FF |
| NS | Non-submission of work by published deadline or non-attendance for examination |
| Module Requirements | |
|---|---|
| Prerequisites for Module | Successful completion of Stage 2 of the course, or equivalent. |
| Corequisites for module | None. |
| Precluded Modules | None. |
| INDICATIVE BIBLIOGRAPHY | |
|---|---|
| 1 | HALL, A., SCOTT, C.,and BUCKLAND, M. Clinical Immunology. Current edition. Oxford University Press. |
| 2 | DELVES, P.J., MARTIN, S.J., BURTON, D.R and ROITT, I.M. Roitt's Essential Immunology. Current Edition. Wiley-Blackwell Publishing. |